Association of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma

J Invest Dermatol. 2016 Jun;136(6):1302-1305. doi: 10.1016/j.jid.2015.12.047. Epub 2016 Feb 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Squamous Cell / chemically induced*
  • Female
  • Genes, ras
  • Humans
  • Indoles / adverse effects*
  • Pipobroman / adverse effects*
  • Protein Multimerization / drug effects*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Proto-Oncogene Proteins B-raf / chemistry*
  • Skin Neoplasms / chemically induced*
  • Sulfonamides / adverse effects*
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • Pipobroman
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf